We are live on
!
Find out more
Amneal Pharmaceuticals
AMRX
AMRX
167 hedge funds and large institutions have $2.41B invested in Amneal Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 57 increasing their positions, 48 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
61.76% more ownership
Funds ownership: 32.68% → 94.44% (+62%)
50% more capital invested
Capital invested by funds: $1.6B → $2.41B (+$807M)
20% more call options, than puts
Call options by funds: $1.47M | Put options by funds: $1.22M
19% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 48
3% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 35
1% more funds holding
Funds holding: 166 → 167 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
167
Holders Change
+1
Holders Change %
+0.6%
% of All Funds
3.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
36
Increased
57
Reduced
48
Closed
35
Calls
$1.47M
Puts
$1.22M
Net Calls
+$244K
Net Calls Change
+$968K
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$232M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$44.1M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$42.2M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$32.4M |
| 5 |
HM
HealthCor Management
New York
|
+$21.8M |
Top Sellers
| 1 |
MC
Maverick Capital
Dallas,
Texas
|
-$45.7M |
| 2 |
Millennium Management
New York
|
-$32.7M |
| 3 |
Fisher Asset Management
Camas,
Washington
|
-$24M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$23.3M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
-$15.6M |
